| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
JUPITER, Fla.—Scientists from the Florida campus of The Scripps Research Institute have discovered a mechanism that plays a critical role in the formation of long-term memory, finding that are said to "shed substantial new light on aspects of how memory is formed" and could lead to novel treatments for memory disorders.

In the study, published as the cover story of the journal Neuron on August 26, the scientists found that a main driver of memory formation is myosin II, a motor protein critical to cell movement and growth.

"By showing for the first time that myosin II acts as the principal organizer of memory formation, we are that much closer to identifying the signaling pathways that activate this motor protein in the brain," says Gavin Rumbaugh, an assistant professor in the Department of Neuroscience at Scripps Florida who led the study. "Once we're able to do that, we can begin to develop potential treatments that could restore memory in people who suffer from cognitive disorders like Alzheimer's disease."

In the study, Rumbaugh and his colleagues showed that myosin II mediates a mechanical process that is part of the complex process of memory formation.

Specifically, myosin II links together the initiation of long-term potentiation, a process that enhances signal transmission between two neurons in the creation of memory, the stabilization synapses' ability to maintain this enhanced transmission, and the reorganization of neurons' F-actin, a cellular polymer that enables growth of synapses.

"Stimulation in the brain turns on these myosin motors and this triggers the growth of F-actin that ultimately solidifies the enhancement of neuronal communication," Rumbaugh explains. "Growth and strengthening of synapses is a process that the brain uses to record our experiences. We are just now beginning to understand the physical substrates within synapses that enable the storage of our life experiences."

He adds that the role of F-actin described in the study is consistent with the long-standing idea that long-term potentiation is dependent on changes to the synaptic architecture, suggesting the dynamic reorganization triggered by myosin II represents an early step in information encoding.

"Many parallel brain processes have to be activated to store information," he says. "If any one of them is disrupted, the information doesn't get stabilized and the memory is lost. Myosin II is a central regulator of this process and if you could pharmacologically control myosin II, you could potentially regulate memories at will."

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue